Literature DB >> 2510839

Lessons from the cardiac arrhythmia suppression trial.

C Garratt1, D E Ward, A J Camm.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2510839      PMCID： PMC1837677          DOI： 10.1136/bmj.299.6703.805

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  2 in total

1.  Death following withdrawal of encainide.

Authors:  G S Thomas
Journal:  N Engl J Med       Date:  1989-08-10       Impact factor: 91.245

2.  Flecainide-induced ventricular tachycardia and fibrillation in patients treated for atrial fibrillation.

Authors:  R H Falk
Journal:  Ann Intern Med       Date:  1989-07-15       Impact factor: 25.391
  2 in total
  4 in total

1.  Recasting the approach to the treatment of potentially malignant ventricular arrhythmias after the CAST study.

Authors:  A Bayés de Luna; J Guindo; J Borja; M Roman; C Madoery
Journal:  Cardiovasc Drugs Ther       Date:  1990-06       Impact factor: 3.727

Review 2.  Encainide--an updated safety profile.

Authors:  J A Thomis
Journal:  Cardiovasc Drugs Ther       Date:  1990-06       Impact factor: 3.727

Review 3.  Are outcomes reported in surgical randomized trials patient-important? A systematic review and meta-analysis.

Authors:  Sam Adie; Ian A Harris; Justine M Naylor; Rajat Mittal
Journal:  Can J Surg       Date:  2017-04       Impact factor: 2.089

4.  Trials in adult critical care that show increased mortality of the new intervention: Inevitable or preventable mishaps?

Authors:  James A Russell; Mark D Williams
Journal:  Ann Intensive Care       Date:  2016-02-24       Impact factor: 6.925
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.